Biography:
Lloyd is a scientist with 25-year experience in drug development and clinical trials management. He is an inventor with a number of patents in drug therapeutics in the treatment of neurological and metabolic diseases. Lloyd serves as the Chairman & Chief Scientific Officer of Biomed Industries, Inc., the parent company of Biomed Pharmaceuticals, NeuroActiva, Biomed AI and MedAware Systems, Inc. In his early career, he was employed as a research scientist at G.D. Searle, (a subsidiary of Pfizer), and was the director of R&D at Biomed Pharmaceuticals. Lloyd graduated with a BSc (Honours) and completed a PhD in medicinal chemistry at University of Otago and Wellington University of New Zealand.
NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss